Curaleaf Holdings, Inc.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in New York, NY.

Green Thumb Industries Inc.

The state's cannabis industry regulator says the contaminated product was on sale at 30 dispensaries.

Nevada Issues Health Advisory for Tainted Marijuana

The Cannabis Control Commission would like to reduce the waiting period to "only" 60 days or so.

Massachusetts Pot Regulator Wants to Cut License Wait Time in Half

MedMen Enterprises Inc.

A popular cannabis banking reform measure looks destined to die in the Senate.

Bank on It: The SAFE Banking Act Won't Pass in 2020

The company must also support research activities after being awarded Clinical Registrant status by the state.

Curaleaf Cleared to Open Medical Marijuana Dispensaries in Pennsylvania

Chances are that you've never even heard of Curaleaf's top competitor.

This Pot Stock May Surpass Curaleaf to Become the Largest U.S. Dispensary Operator

The company, which is pending a buyout by Curaleaf, sells 10 properties in a sale-leaseback arrangement.

Curaleaf's Grassroots Enters Real Estate Deal Worth Nearly $20 Million

Trulieve Cannabis Corp.

Being able to translate retail licenses into operational dispensaries should mean a lot of revenue for these marijuana stocks.

These U.S. Pot Stocks Have the Most Open Dispensaries

Aurora Cannabis

HEXO Corp

Their stock prices could continue falling.

3 Reasons Canadian Pot Stocks Still Aren't Good Buys

Canopy Growth

Here's where President Trump stands on cannabis, and what his possible re-election might mean for the U.S. pot industry.

Donald Trump and Marijuana: Everything You Need to Know

The cannabis company said the deal announced in July should finally close this spring.

Curaleaf's Acquisition of Grassroots Chain Clears a Regulatory Hurdle

These cannabis stocks could put the "green" in green rush.

4 Pot Stocks Capable of $1 Billion in Annual Sales by 2022

The state's cannabis regulator has received around 170 bids for business licenses.

Applications Surge for Recreational Marijuana Licenses in Maine

That result was higher than expected, and indicates robust growth.

Arkansas Medical Pot Sales Top $10 Million Year-to-Date

Curaleaf has been outperforming the cannabis sector by a wide margin.

This Pot Stock Is Up Around 50% in 3 Months. Can It Continue Soaring?

The company's new outlet will be located in the town of Ware.

Curaleaf Wins Its Third Recreational Marijuana Retail License in Massachusetts

The winners will help provide the tech foundation supporting the state's medical marijuana industry.

Missouri Announces First Seed-to-Sale Cannabis Licenses

The deal was originally announced in May 2019.

Curaleaf Closes Long-Simmering Select Acquisition

These marijuana stocks have the broadest reach in the most lucrative cannabis market in the world.

6 U.S. Pot Stocks Operating in at Least 10 States

Professional athletics and the hemp by-product will make for an odd combination.

Sports Illustrated CBD Product Line to Debut

In a settlement, Cura Partners will fork over $110,000 to Oregon's cannabis regulator.

Curaleaf Acquisition to Pay Record Fine for Mislabeling Products

The rollout will be cautious, however, with only one or two stores open at the start of the program.

Utah Medical Pot Dispensaries to Start Opening in March

The store is located in the busy Cape municipality of Provincetown.

Curaleaf Opens First Recreational Cannabis Dispensary on Cape Cod

Some notable marijuana stocks were on the long list of applicants.

Missouri Begins Licensing 192 Medical Pot Dispensaries

It's the latest in a series of revisions agreed to by the cannabis company's major shareholders.

Curaleaf Modifies Lockup Agreement Again

Thieves are targeting pot businesses because they know they primarily operate in cash.

News for Curaleaf Holdings, Inc. Stock (CURLF)